02.10.2017 • News

Praxair Shareholders Approve Merger with Linde

(c) Linde
(c) Linde

Praxair’s shareholders have overwhelmingly approved the proposed merger with Linde. At a special shareholders meeting on Sept. 27, about 83% of the total issued and outstanding shares of Praxair common stock was in favor of the deal, exceeding the required majority and representing approximately 99% of the total votes cast.

“Today’s vote confirms that Praxair shareholders support this transaction and brings us one step closer to creating a world-class leader in the industrial gas industry,” said Steve Angel, Praxair’s chairman and CEO.

The approval is an essential step toward combining the two major industrial gases group under new holding company, Linde plc. However, 75% of Linde’s shareholders must tender their stock to the new company by Oct. 24 for the merger to go ahead, as well as obtaining antitrust approvals and fulfilling other customary closing conditions.

Praxair and Linde expect the transaction to complete in the second half of 2018.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.